Chai-Onn Robert Roswell
Insider CIK 1502213 · VRX EVP, Gen. Couns. and Corp. Sec
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VRX Valeant Pharmaceuticals In | A Award | 2016-05-12 | 2016-05-16 | 60,697 | — | $0 | 124,815 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2015-10-20 | 2015-10-22 | 876 | — | $0 | 64,118 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2015-05-05 | 2015-05-06 | 21,807 | — | $0 | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2015-05-05 | 2015-05-06 | 21,807 | $6.10 | $133.0K | 64,994 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2015-05-04 | 2015-05-06 | 90,938 | — | $0 | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2015-05-04 | 2015-05-06 | 90,938 | $222.54 | $20.24M | 43,187 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2015-05-04 | 2015-05-06 | 90,938 | $25.42 | $2.31M | 134,125 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2015-03-03 | 2015-03-04 | 21,808 | — | $0 | 21,807 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2015-03-03 | 2015-03-04 | 21,808 | $6.10 | $133.0K | 43,187 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2015-03-02 | 2015-03-04 | 90,939 | — | $0 | 90,938 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2015-03-02 | 2015-03-04 | 90,939 | $25.42 | $2.31M | 112,296 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2015-03-02 | 2015-03-04 | 90,939 | $200.01 | $18.19M | 21,379 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-10-23 | 2014-10-27 | 876 | — | $0 | 21,379 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2014-07-29 | 2014-07-30 | 1,744 | — | $0 | 22,255 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-06-23 | 2014-06-24 | 10,203 | — | $0 | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2014-06-23 | 2014-06-24 | 10,203 | $121.70 | $1.24M | 23,999 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-06-23 | 2014-06-24 | 10,203 | $6.45 | $65.8K | 34,202 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2014-05-20 | 2014-05-22 | 180,000 | — | $0 | 180,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2014-05-20 | 2014-05-22 | 90,000 | — | $0 | 90,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-05-13 | 2014-05-14 | 10,000 | $6.45 | $64.5K | 10,203 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-05-13 | 2014-05-14 | 10,000 | $6.45 | $64.5K | 33,999 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2014-05-13 | 2014-05-14 | 10,000 | $130.08 | $1.30M | 23,999 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2014-03-17 | 2014-03-19 | 5,000 | — | $0 | 20,203 | SEC↗ |
| VRX Valeant Pharmaceuticals In | S Sale | 2014-03-17 | 2014-03-19 | 5,000 | $141.72 | $708.6K | 23,999 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2014-03-17 | 2014-03-19 | 5,000 | $6.45 | $32.3K | 28,999 | SEC↗ |
| VRX Valeant Pharmaceuticals In | G Gift | 2013-12-14 | 2013-12-19 | 82,995 | — | $0 | 23,999 | SEC↗ |
| VRX Valeant Pharmaceuticals In | G Gift | 2013-12-14 | 2013-12-19 | 82,995 | — | $0 | 82,995 | SEC↗ |
| VRX Valeant Pharmaceuticals In | G Gift | 2013-12-13 | 2013-12-19 | 30,000 | — | $0 | 189,989 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award deriv | 2013-12-12 | 2013-12-13 | 180,000 | — | $0 | 180,000 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-10-24 | 2013-10-28 | 58,204 | — | $0 | 0 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-10-24 | 2013-10-28 | 58,204 | — | $0 | 250,606 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-10-24 | 2013-10-28 | 30,617 | — | $0 | 219,989 | SEC↗ |
| VRX Valeant Pharmaceuticals In | A Award | 2013-10-20 | 2013-10-22 | 5,032 | — | $0 | 192,402 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-10-08 | 2013-10-10 | 907 | — | $0 | 187,370 | SEC↗ |
| VRX Valeant Pharmaceuticals In | P Buy | 2013-08-23 | 2013-08-23 | 5,032 | $99.30 | $499.7K | 188,277 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-07-26 | 2013-07-30 | 19,401 | — | $0 | 58,204 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-07-26 | 2013-07-30 | 19,401 | — | $0 | 193,448 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-07-26 | 2013-07-30 | 10,203 | — | $0 | 183,245 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-07-25 | 2013-07-29 | 1,749 | — | $0 | 174,047 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2013-05-31 | 2013-06-04 | 77,605 | — | $0 | 77,605 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2013-05-31 | 2013-06-04 | 77,605 | — | $0 | 294,648 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2013-05-31 | 2013-06-04 | 40,585 | — | $0 | 254,063 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-10-08 | 2012-10-10 | 797 | — | $0 | 217,043 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-10-04 | 2012-10-04 | 36,323 | — | $0 | 217,840 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-10-04 | 2012-10-04 | 36,323 | — | $0 | 217,840 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise deriv | 2012-09-26 | 2012-09-28 | 77,605 | — | $0 | 77,605 | SEC↗ |
| VRX Valeant Pharmaceuticals In | M Exercise | 2012-09-26 | 2012-09-28 | 77,605 | — | $0 | 254,163 | SEC↗ |
| VRX Valeant Pharmaceuticals In | F Tax w/h | 2012-07-25 | 2012-07-27 | 1,216 | — | $0 | 176,558 | SEC↗ |